CDK4 and neoplasm: Compounds thatantagonized CDK4/6 activity were observed to elicit their activities via bothcell types, as T-cell anti-tumor activity was observed under both tumorspheroid-only treatment and T-cell-only treatment (SupplementaryFig. 5).